SUNREST logo

Sunrest Lifescience LTD

SUNREST·NSE·
36.50 -3.10 (-7.83%)
Market Cap69.69 Cr
PE Ratio7.60
Volume9,600
Day High - Low40.70 - 36.50
52W High-Low54.00 - 29.55
DocStoX Score
6.8/10
Fair
Fair Value
Sign in to see
ROE
22.40%
Strong
P/E
7.60x
Cheap
Debt / Equity
0.85
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day36.50
40.70
52W29.55
54.00
DocStoX take

Supported by growth (10.0) and valuation (9.0), but held back by momentum (1.9). Growth looks strong at 10.0, but that is offset by momentum at 1.9. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.8
/10
Fair
Quality
Solid
ROE 22.4%
Valuation
Cheap
P/E 7.6×
Growth
Strong
Revenue +33.1% 5Y CAGR
Risk
Moderate
D/E 0.85
Momentum
Weak
28% of 52-week range

At a glance

Market Cap
₹70 Cr
52W High / Low
₹54 / ₹30
Dividend Yield
0.00%
Promoter Holding
53.50%
EPS (TTM)
₹4.80
Book Value
₹23.80

Key highlights

  • Profit compounding 116% a year
  • Revenue compounding 33% a year
  • Capital works hard — ROCE 29%
  • Momentum is weak (1.9/10)
  • Small ₹70 cr company — thinner liquidity
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

SUNREST LIFESCIENCE LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.